[Determination of leucine arylamidase (LAS) activity in the urine during the monitoring of cisplatin nephrotoxicity in oncologic diseases].
D002945:Cisplatin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D007931:Leucyl Aminopeptidase / Q000652:urine*; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology*
D007931:Leucyl Aminopeptidase; D002945:Cisplatin
Stanovení aktivity leucinarylamidázy (LAS) v moci pri sledování nefrotoxicity cis-platiny u onkologických nemocných.